Cargando…

Incidence of Hyperglycemia/Secondary Diabetes in Women who have Undergone Curative Chemotherapy for Breast Cancer: First Study from India

Purpose  Development of cancer chemotherapy treatment-induced hyperglycemia/ diabetes (secondary diabetes) is a major problem and has never been reported from India. The present study was planned to ascertain this in women undergoing curative chemotherapy for their breast cancer. Materials and Metho...

Descripción completa

Detalles Bibliográficos
Autores principales: Rao, Suresh, Prasad, Krishna, Abraham, Soniya, George, Thomas, Chandran, Supreeth Kakkaje, Baliga, Manjeshwar Shrinath
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical and Scientific Publishers Pvt. Ltd. 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075627/
https://www.ncbi.nlm.nih.gov/pubmed/33937134
http://dx.doi.org/10.1055/s-0041-1723104
_version_ 1783684553164980224
author Rao, Suresh
Prasad, Krishna
Abraham, Soniya
George, Thomas
Chandran, Supreeth Kakkaje
Baliga, Manjeshwar Shrinath
author_facet Rao, Suresh
Prasad, Krishna
Abraham, Soniya
George, Thomas
Chandran, Supreeth Kakkaje
Baliga, Manjeshwar Shrinath
author_sort Rao, Suresh
collection PubMed
description Purpose  Development of cancer chemotherapy treatment-induced hyperglycemia/ diabetes (secondary diabetes) is a major problem and has never been reported from India. The present study was planned to ascertain this in women undergoing curative chemotherapy for their breast cancer. Materials and Methods  This was a retrospective chart-based study and was conducted in a cancer specialty hospital. The information on women who were nondiabetic at the start of the treatment was collected from the files. Details on cancer diagnosis, domicile, body mass index (BMI), type of diet, marital status, number of children, and previous history of diabetes if any were considered. The blood glucose levels before surgery and after the completion of radiotherapy were considered. World Health Organization (WHO) guidelines for diabetes were considered. The data were subjected to frequency and percentage and analyzed using Chi-square test. Association between the demographic details and development of Hyperglycemia or secondary diabetes or prediabetes was done using the Pearson’s correlation analysis. p < 0.05 was considered as statistically significant. Results  A total of 474 cases were included in accordance with the inclusion criteria. The results indicated that by the end of the radiation treatment, 24.89% were prediabetic, 10.97% were diabetic after being in prediabetic stage, 8.22% became diabetic without going through a prediabetic stage, and that 55.91% did not develop either prediabetic or diabetic condition. Analysis of development of secondary diabetes and prediabetes with BMI ( p < 0.0001) and age ( p < 0.024) showed a strong correlation and was significant. Conclusion  To the best of the authors’ knowledge, this is the first study from India, and the results indicate that the development of secondary diabetes in women undergoing curative chemotherapy is high. Attempts are underway to ascertain the cause for the development and how it can be mitigated.
format Online
Article
Text
id pubmed-8075627
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Thieme Medical and Scientific Publishers Pvt. Ltd.
record_format MEDLINE/PubMed
spelling pubmed-80756272021-04-29 Incidence of Hyperglycemia/Secondary Diabetes in Women who have Undergone Curative Chemotherapy for Breast Cancer: First Study from India Rao, Suresh Prasad, Krishna Abraham, Soniya George, Thomas Chandran, Supreeth Kakkaje Baliga, Manjeshwar Shrinath South Asian J Cancer Purpose  Development of cancer chemotherapy treatment-induced hyperglycemia/ diabetes (secondary diabetes) is a major problem and has never been reported from India. The present study was planned to ascertain this in women undergoing curative chemotherapy for their breast cancer. Materials and Methods  This was a retrospective chart-based study and was conducted in a cancer specialty hospital. The information on women who were nondiabetic at the start of the treatment was collected from the files. Details on cancer diagnosis, domicile, body mass index (BMI), type of diet, marital status, number of children, and previous history of diabetes if any were considered. The blood glucose levels before surgery and after the completion of radiotherapy were considered. World Health Organization (WHO) guidelines for diabetes were considered. The data were subjected to frequency and percentage and analyzed using Chi-square test. Association between the demographic details and development of Hyperglycemia or secondary diabetes or prediabetes was done using the Pearson’s correlation analysis. p < 0.05 was considered as statistically significant. Results  A total of 474 cases were included in accordance with the inclusion criteria. The results indicated that by the end of the radiation treatment, 24.89% were prediabetic, 10.97% were diabetic after being in prediabetic stage, 8.22% became diabetic without going through a prediabetic stage, and that 55.91% did not develop either prediabetic or diabetic condition. Analysis of development of secondary diabetes and prediabetes with BMI ( p < 0.0001) and age ( p < 0.024) showed a strong correlation and was significant. Conclusion  To the best of the authors’ knowledge, this is the first study from India, and the results indicate that the development of secondary diabetes in women undergoing curative chemotherapy is high. Attempts are underway to ascertain the cause for the development and how it can be mitigated. Thieme Medical and Scientific Publishers Pvt. Ltd. 2020-07 2021-03-19 /pmc/articles/PMC8075627/ /pubmed/33937134 http://dx.doi.org/10.1055/s-0041-1723104 Text en MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/). https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.
spellingShingle Rao, Suresh
Prasad, Krishna
Abraham, Soniya
George, Thomas
Chandran, Supreeth Kakkaje
Baliga, Manjeshwar Shrinath
Incidence of Hyperglycemia/Secondary Diabetes in Women who have Undergone Curative Chemotherapy for Breast Cancer: First Study from India
title Incidence of Hyperglycemia/Secondary Diabetes in Women who have Undergone Curative Chemotherapy for Breast Cancer: First Study from India
title_full Incidence of Hyperglycemia/Secondary Diabetes in Women who have Undergone Curative Chemotherapy for Breast Cancer: First Study from India
title_fullStr Incidence of Hyperglycemia/Secondary Diabetes in Women who have Undergone Curative Chemotherapy for Breast Cancer: First Study from India
title_full_unstemmed Incidence of Hyperglycemia/Secondary Diabetes in Women who have Undergone Curative Chemotherapy for Breast Cancer: First Study from India
title_short Incidence of Hyperglycemia/Secondary Diabetes in Women who have Undergone Curative Chemotherapy for Breast Cancer: First Study from India
title_sort incidence of hyperglycemia/secondary diabetes in women who have undergone curative chemotherapy for breast cancer: first study from india
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075627/
https://www.ncbi.nlm.nih.gov/pubmed/33937134
http://dx.doi.org/10.1055/s-0041-1723104
work_keys_str_mv AT raosuresh incidenceofhyperglycemiasecondarydiabetesinwomenwhohaveundergonecurativechemotherapyforbreastcancerfirststudyfromindia
AT prasadkrishna incidenceofhyperglycemiasecondarydiabetesinwomenwhohaveundergonecurativechemotherapyforbreastcancerfirststudyfromindia
AT abrahamsoniya incidenceofhyperglycemiasecondarydiabetesinwomenwhohaveundergonecurativechemotherapyforbreastcancerfirststudyfromindia
AT georgethomas incidenceofhyperglycemiasecondarydiabetesinwomenwhohaveundergonecurativechemotherapyforbreastcancerfirststudyfromindia
AT chandransupreethkakkaje incidenceofhyperglycemiasecondarydiabetesinwomenwhohaveundergonecurativechemotherapyforbreastcancerfirststudyfromindia
AT baligamanjeshwarshrinath incidenceofhyperglycemiasecondarydiabetesinwomenwhohaveundergonecurativechemotherapyforbreastcancerfirststudyfromindia